Articles

The ENHANCE study, showing no difference between simvastatin plus ezetimibe (Zetia/Vytorin, Merck and Schering-Plough) compared with simvastatin alone on the progression of carotid atherosclerosis in patients with familial hypercholesterolemia, has been a major talking point over the past few days.

The Androgen Excess Society has released a new position statement on glucose intolerance in women with polycystic ovary syndrome.

Low serum concentration of vitamin E, an indication of poor nutrition, is associated with physical decline for older persons, according to a study in the January 23 issue of JAMA.

Major depression is “highly prevalent” among diabetic patients, and need to be screened, according to findings in a new study in Diabetes Care.

Insulin resistance in certain islet cell antibody (ICA)-positive relatives of patients with type 1 diabetes appears to accelerate onset of the disease, according to the results of a new study.

Coronary heart disease (CHD) risk in women may be increased at lower glucose levels than in men.

Taranabant, a novel cannabinoid 1 (CB1) receptor inverse agonist, induces weight loss by reducing appetite by reducing caloric intake by 22% and increasing energy expenditure and fat oxidation, according to a compilation of research data from a new study.

Danish drugmaker Novo Nordisk said on Monday it was halting development of its AERx inhaled insulin product and will lay off most of the approximately 300 company employees working on the product.

Generex Biotechnology Corporation announces it will begin marketing their Oral-lyn Insulin, which gets absorbed through the inner lining of the mouth.

Patients with diabetes fare better in family practices that employ a nurse practitioner than in practices with a physician’s assistant or those without a mid-level provider, investigators found.